Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Exercise During Chemotherapy for Patients With Hematological Malignancies

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2009 by Charite University, Berlin, Germany.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Charite University, Berlin, Germany
ClinicalTrials.gov Identifier:
NCT00884364
First received: April 17, 2009
Last updated: December 21, 2009
Last verified: December 2009

April 17, 2009
December 21, 2009
May 2009
April 2011   (final data collection date for primary outcome measure)
Fatigue [ Time Frame: At recruitment and after 12 weeks ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00884364 on ClinicalTrials.gov Archive Site
  • Complications [ Time Frame: At recruitment and after 12 weeks ] [ Designated as safety issue: No ]
  • Physical performance [ Time Frame: At recruitment and after 12 weeks ] [ Designated as safety issue: Yes ]
Same as current
Not Provided
Not Provided
 
Exercise During Chemotherapy for Patients With Hematological Malignancies
Exercise During Chemotherapy for Patients With Hematological Malignancies

The trial will evaluate the effects of aerobic exercise in patients undergoing chemotherapy for the treatment of a hematological neoplastic disease.

Not Provided
Interventional
Phase 3
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Investigator)
  • Hematological Diseases
  • Hematological Malignancies
  • Other: Aerobic exercise
    The patients will carry out an aerobic exercise program consisting of walking on a treadmill for 30 minutes at an intensity of 80% of the maximum heart rate. The training will be carried out three times a week.
  • Behavioral: Fatigue counseling
    The patients will receive a counseling regarding the causes of fatigue, how to cope with this symptom, and general recommendations about exercise. However, they will not participate at a structured exercise program.
  • Active Comparator: Control
    Intervention: Behavioral: Fatigue counseling
  • Experimental: Exercise
    Intervention: Other: Aerobic exercise
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
60
September 2011
April 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Hematological malignant disease
  • Current chemotherapy
  • Understanding of written German

Exclusion Criteria:

  • Cardiorespiratory, metabolical, osteoarticular or immunological disorders which can be aggravated by exercise
  • Pathological stress-ECG at recruitment
Both
18 Years to 70 Years
No
Contact: Fernando Dimeo, MD +493084452098 fernando.dimeo@charite.de
Germany
 
NCT00884364
EA4/031/09
No
Dr. Fernando Dimeo, Dept. of Sports Medicine, Charité Universitätsmedizin Berlin
Charite University, Berlin, Germany
Not Provided
Principal Investigator: Fernando Dimeo, MD Charite University, Berlin, Germany
Charite University, Berlin, Germany
December 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP